Age-Related Macular Degeneration & Retinal Health Protocol
Age-Related Macular Degeneration & Retinal Health Protocol framework focused on consistent execution, practical monitoring, and safer progression.
A protocol targeting the mitochondrial dysfunction, oxidative stress, and complement-mediated inflammation driving age-related macular degeneration and retinal aging through mitochondria-targeted peptides and antioxidant signaling.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Age-Related Macular Degeneration & Retinal Health Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
Ongoing maintenance; Epithalon as periodic 10-day cycles. All others continuous.
Target Audience
Adults 50+ with early-to-intermediate dry AMD, family history of AMD, or seeking retinal health preservation
| Compound | Dose | Frequency |
|---|---|---|
| SS-31 (Elamipretide) SS-31: concentrates in mitochondria via cardiolipin; reduces ROS in retinal pigment epithelium; slows drusen accumulation and photoreceptor loss | 2-5 mg | 3x/week SC |
| Humanin Humanin: mitochondria-derived peptide; protects retinal ganglion cells from amyloid-beta toxicity; circulating levels decline in AMD patients | 2-4 mg | Daily SC |
| MOTS-c MOTS-c: activates AMPK in RPE cells; restores mitophagy to clear damaged retinal mitochondria; declines with age mirroring AMD onset | 5-10 mg | 3x/week SC |
| NAD+ NAD+/NMN: restores SIRT1/SIRT3 activity in aging retinal cells; reduces complement activation and supports mitochondrial biogenesis in RPE | 500 mg NMN | Once daily oral |
| GHK-Cu GHK-Cu: downregulates VEGF expression; stimulates antioxidant genes (SOD2, catalase) in retinal tissue; anti-inflammatory in RPE | 1-2 mg | 5x/week SC |
| Epithalon Epithalon: activates telomerase in photoreceptors; restores pineal melatonin with potent retinal antioxidant effects; protects retinal function in aging models | 5-10 mg | Daily SC for 10-day cycles, 2x/year |
Free Peptide Guide
Age-Related Macular Degeneration & Retinal Health Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned SS-31 (Elamipretide) timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Age-Related Macular Degeneration & Retinal Health Protocol run before reassessment?
A common window is Ongoing maintenance; Epithalon as periodic 10-day cycles. All others continuous., with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with SS-31 (Elamipretide) + Humanin execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
AMD is fundamentally a disease of retinal pigment epithelium (RPE) mitochondrial dysfunction, cumulative oxidative damage, and chronic complement activation. SS-31 concentrates in mitochondria via cardiolipin binding and reduces ROS production in RPE cells, slowing drusen accumulation. Humanin, a mitochondria-derived peptide, protects retinal ganglion cells against amyloid-beta toxicity. MOTS-c activates AMPK in RPE cells to restore mitophagic clearance of damaged organelles. NAD+ via NMN restores SIRT1 and SIRT3 activity in aging retinal cells. GHK-Cu downregulates VEGF expression, potentially slowing neovascularization in wet AMD. Epithalon protects photoreceptors via telomerase activation and melatonin-mediated antioxidant signaling.
Clinical Research
No clinical references were provided for this stack yet.
More Anti-Aging Stacks
Advanced Comprehensive Anti-Aging Stack
An advanced multi-pathway longevity protocol combining telomere restoration, mitochondrial optimization, autophagy induction, epigenetic reprogramming, and systemic regeneration for experienced biohackers.
Age-Related Macular Degeneration & Eye Health Protocol
Neuroprotective and anti-angiogenic peptide protocol to slow AMD progression, support retinal cell survival, and reduce oxidative damage in the aging eye.
Anti-Aging Cellular Stress Response & Hormesis
Activates the body's intrinsic stress response pathways (hormesis) to build resilience against aging: heat shock proteins, autophagy, antioxidant defense, and epigenetic repair.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Age-Related Macular Degeneration & Retinal Health Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.